Skip to main content

City Therapeutics, Inc.

CTY
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0002143850

In the last 90 days, City Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.

Holders of 5% or more of CTY

Holders whose latest Schedule 13D or 13G filing reports 5% or more of City Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of CTY
HolderLatest formStakeChangeFirst filedLatest filingFiling
ARCH Venture Fund XII, L.P.13D25.60%13.7M sharesNewOct 26, 20261 filingOct 26, 2026SEC
FMR LLC13G14.00%7.03M sharesNewNov 6, 20261 filingNov 6, 2026SEC
Invus Global Management, LLC13G8.10%4.34M sharesNewOct 22, 20261 filingOct 22, 2026SEC
Viking Global Investors LPSuperinvestorViking Global Investors13G7.00%3.73M sharesNewOct 26, 20261 filingOct 26, 2026SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

4 Schedule 13D and 13G filings on City Therapeutics, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on CTY
Filed (ET)FilerFormStakeChangeEvent dateFiling
Nov 6, 20269:46 AM ETFMR LLCand 1 other13G14.00%7.03M sharesNewOct 30, 2026SEC
Oct 26, 20264:34 PM ETARCH Venture Fund XII, L.P.and 6 others13D25.60%13.7M sharesNewOct 19, 2026SEC
Oct 26, 20264:25 PM ETViking Global Investors LPand 9 othersSuperinvestorViking Global Investors13G7.00%3.73M sharesNewOct 19, 2026SEC
Oct 22, 20261:15 PM ETInvus Global Management, LLCand 7 others13G8.10%4.34M sharesNewOct 16, 2026SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell City Therapeutics, Inc. shares.

No Form 144 notices for City Therapeutics, Inc. are on file.